Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NuCel Labs, primarily known as a division or brand of NuTech Medical (now a subsidiary of Organogenesis), is a biotechnology company specializing in regenerative medicine and advanced tissue engineering. The company focuses on the development of allografts derived from human placental and amniotic tissues to enhance healing in surgical and wound care applications. Its flagship product, NuCel, is a cryopreserved amniotic fluid-derived allograft used primarily in spinal fusion and orthopedic procedures. The technology provides a natural scaffold and essential growth factors to support tissue regeneration and reduce inflammation. Originally a brand or division of NuTech Medical, the entity was acquired by Organogenesis in 2017. Today, its products are part of a broader portfolio of regenerative solutions targeting orthopedics, sports medicine, and chronic wound management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NuCel Labs.